Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Antares and Population Council initiate phase II contraceptive ATD Gel trial

Nov. 26, 2008

Novel therapeutic agents for cancer cachexia and muscle wasting imparted in recent Santhera patent

Nov. 26, 2008

Recent GSK patent claims new 5-HT1A receptor antagonists for premature ejaculation

Nov. 26, 2008

Metabolon and Joslin Diabetes Center to collaborate in area of insulin resistance and diabetes

Nov. 26, 2008

FDA accepts DX-88 filing and grants priority review for hereditary angioedema

Nov. 25, 2008

Essentialis completes patient enrollment in phase II DCCR trial

Nov. 25, 2008

Takeda submits European MAA for once-daily Competact formulation

Nov. 24, 2008

Biovitrum reports positive results from clinical trial of Sym-001 in HDN

Nov. 24, 2008

GlaxoSmithKline receives FDA accelerated approval for Promacta

Nov. 21, 2008

Elixir's reports results from phase III trial of metformin-mitiglinide therapy

Nov. 21, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...